Amylyx Pharmaceuticals Inc
NASDAQ:AMLX

Watchlist Manager
Amylyx Pharmaceuticals Inc Logo
Amylyx Pharmaceuticals Inc
NASDAQ:AMLX
Watchlist
Price: 4.05 USD 2.27% Market Closed
Market Cap: 277.6m USD
Have any thoughts about
Amylyx Pharmaceuticals Inc?
Write Note

Balance Sheet

Balance Sheet Decomposition
Amylyx Pharmaceuticals Inc

Current Assets 245.3m
Cash & Short-Term Investments 234.4m
Receivables 1.7m
Other Current Assets 9.1m
Non-Current Assets 5.5m
PP&E 3.5m
Other Non-Current Assets 1.9m
Current Liabilities 53.9m
Accounts Payable 1.5m
Accrued Liabilities 52.4m
Non-Current Liabilities 595k
Other Non-Current Liabilities 595k

Balance Sheet
Amylyx Pharmaceuticals Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
3
13
50
63
170
Cash Equivalents
3
13
50
63
170
Short-Term Investments
0
0
46
284
201
Total Receivables
0
0
0
15
40
Accounts Receivables
0
0
0
15
40
Other Receivables
0
0
0
0
0
Inventory
0
0
0
10
38
Other Current Assets
0
1
9
10
15
Total Current Assets
3
14
105
382
465
PP&E Net
0
0
1
8
6
PP&E Gross
0
0
1
8
6
Accumulated Depreciation
0
0
0
1
2
Other Long-Term Assets
0
0
0
1
46
Total Assets
3
N/A
14
+341%
106
+649%
392
+271%
517
+32%
Liabilities
Accounts Payable
2
4
4
6
22
Accrued Liabilities
2
4
13
40
60
Short-Term Debt
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
0
Total Current Liabilities
5
7
17
47
82
Long-Term Debt
15
0
0
0
0
Other Liabilities
1
1
0
4
2
Total Liabilities
21
N/A
9
-58%
17
+98%
51
+192%
84
+65%
Equity
Common Stock
8
72
239
0
0
Retained Earnings
26
68
156
354
305
Additional Paid In Capital
0
1
5
695
738
Other Equity
0
0
0
0
0
Total Equity
18
N/A
5
N/A
88
+1 564%
341
+286%
433
+27%
Total Liabilities & Equity
3
N/A
14
+341%
106
+649%
392
+271%
517
+32%
Shares Outstanding
Common Shares Outstanding
57
57
57
67
68
Preferred Shares Outstanding
0
0
37
0
0

See Also

Discover More